Unknown NA INTERVENTIONAL 1-arm NCT05626842

The DR-EAM Type 2 Diabetes Study

The 'DR-EAM' Study - (Type 2) Diabetes Weight Reduction - Evaluation of Appcoaching Model

Sponsor: Oviva UK Ltd

Interventions Total Diet Replacement (800kcal/day)

Updated 4 times since 2022 Last updated: Nov 15, 2022 Started: Jan 20, 2021 Primary completion: Sep 30, 2023 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Type 2 Diabetes and is currently ongoing. Oviva UK Ltd leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Dec 2024 — Present [monthly]

Unknown NA

Status: Active Not Recruiting → Unknown
Sep 2024 — Dec 2024 [monthly]

Active Not Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting NA
Dec 2022 — Jul 2024 [monthly]

Active Not Recruiting NA

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oviva UK Ltd
University of Westminster

Data source: Oviva UK Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom